135 related articles for article (PubMed ID: 15272144)
1. Insights into oxidative stress and potential novel therapeutic targets for Alzheimer disease.
Maiese K; Chong ZZ
Restor Neurol Neurosci; 2004; 22(2):87-104. PubMed ID: 15272144
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
3. Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment.
Frölich L; Riederer P
Arzneimittelforschung; 1995 Mar; 45(3A):443-6. PubMed ID: 7763342
[TBL] [Abstract][Full Text] [Related]
4. The cell cycle in Alzheimer disease: a unique target for neuropharmacology.
Webber KM; Raina AK; Marlatt MW; Zhu X; Prat MI; Morelli L; Casadesus G; Perry G; Smith MA
Mech Ageing Dev; 2005 Oct; 126(10):1019-25. PubMed ID: 15936057
[TBL] [Abstract][Full Text] [Related]
5. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.
Chong ZZ; Li F; Maiese K
Brain Res Brain Res Rev; 2005 Jul; 49(1):1-21. PubMed ID: 15960984
[TBL] [Abstract][Full Text] [Related]
6. Involvement of oxidative stress in Alzheimer disease.
Nunomura A; Castellani RJ; Zhu X; Moreira PI; Perry G; Smith MA
J Neuropathol Exp Neurol; 2006 Jul; 65(7):631-41. PubMed ID: 16825950
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
9. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?
Moreira PI; Smith MA; Zhu X; Honda K; Lee HG; Aliev G; Perry G
Drug News Perspect; 2005; 18(1):13-9. PubMed ID: 15753972
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
Crouch PJ; Harding SM; White AR; Camakaris J; Bush AI; Masters CL
Int J Biochem Cell Biol; 2008; 40(2):181-98. PubMed ID: 17804276
[TBL] [Abstract][Full Text] [Related]
11. Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease.
Bica L; Crouch PJ; Cappai R; White AR
Mol Biosyst; 2009 Feb; 5(2):134-42. PubMed ID: 19156258
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
13. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid.
Cui X; Zuo P; Zhang Q; Li X; Hu Y; Long J; Packer L; Liu J
J Neurosci Res; 2006 Aug; 84(3):647-54. PubMed ID: 16710848
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture.
Limpeanchob N; Jaipan S; Rattanakaruna S; Phrompittayarat W; Ingkaninan K
J Ethnopharmacol; 2008 Oct; 120(1):112-7. PubMed ID: 18755259
[TBL] [Abstract][Full Text] [Related]
15. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
16. Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Boyd-Kimball D; Sultana R; Abdul HM; Butterfield DA
J Neurosci Res; 2005 Mar; 79(5):700-6. PubMed ID: 15678514
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer' s disease, oxidative stress and gammahydroxybutyrate.
Mamelak M
Neurobiol Aging; 2007 Sep; 28(9):1340-60. PubMed ID: 16837107
[TBL] [Abstract][Full Text] [Related]
18. [The role for oxidative stress in neurodegenerative diseases].
Shibata N; Kobayashi M
Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
[TBL] [Abstract][Full Text] [Related]
19. Prevention of amyloid beta-induced memory impairment by fluvastatin, associated with the decrease in amyloid beta accumulation and oxidative stress in amyloid beta injection mouse model.
Kurinami H; Sato N; Shinohara M; Takeuchi D; Takeda S; Shimamura M; Ogihara T; Morishita R
Int J Mol Med; 2008 May; 21(5):531-7. PubMed ID: 18425343
[TBL] [Abstract][Full Text] [Related]
20. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10.
Somayajulu M; McCarthy S; Hung M; Sikorska M; Borowy-Borowski H; Pandey S
Neurobiol Dis; 2005 Apr; 18(3):618-27. PubMed ID: 15755687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
